Preparation process for agent for treating gout
A production process and technology for pharmaceuticals, applied in the fields of food and medicine, can solve the problems of insignificant effect, large liver damage, involvement of internal organs such as kidneys, etc., and achieve the effects of convenient preparation, low harm and good efficacy.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0015] A preparation process of a medicine for treating gout, the processing process comprising:
[0016] (1) Using broad bean plants, seeds or broad bean skins and broad bean shells as raw materials, the proportioning combination of raw materials is: broad bean skin 35%, broad bean shell 65%.
[0017] (2) adopt ethanol extraction;
[0018] (3) After the ethanol is recovered, it is processed into dosage forms and forms that are convenient to take.
Embodiment 2
[0020] A preparation process of a medicine for treating gout, the processing process comprising:
[0021] (1) Using broad bean plants, seeds or broad bean skins and broad bean shells as raw materials, the proportioning combination of raw materials is: 65% of broad bean plants and 35% of seeds;
[0022] (2) adopt 75% ethanol to extract;
[0023] (3) After the ethanol is recovered, it is processed into dosage forms and forms that are convenient to take.
Embodiment 3
[0025] A preparation process of a medicine for treating gout, the processing process comprising:
[0026] (1) Taking broad bean plants, seeds or broad bean skins and broad bean shells as raw materials, the proportioning combination of raw materials is: broad bean skin 55%, broad bean shell 45%;
[0027] (2) adopt aqueous acetic acid to extract;
[0028] (3) After the pH value is adjusted to cause alkaline precipitation (or insoluble matter), the solvent for pH adjustment adopts potassium dihydrogen phosphate and potassium hydroxide buffer system, and is processed into dosage forms and forms that are convenient for taking.
[0029] The samples of each embodiment are taken for detection and analysis, and compared with the prior art, the following data are obtained:
[0030] flavonoid content Alkaloid content The level of side effects Active ingredients Example 1 1.05g / kg 2.15g / kg Low flavonoids, alkaloids Example 2 0.94g / kg 1.77g / kg Low ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More